About company

Our team is at the interface of synthetic biology and machine learning. We are building a platform to engineer gene therapies that are safer, more effective, and able to address a broader range of diseases. To do that, we work at the interface of genomics, machine learning, and DNA synthesis.

US
Unknown
Not verified company